
Korean Drugmakers Seek Global Collaboration for Open Innovation
The Korea Biomedical Review reported that open innovation has become a major strategy for Korean pharmaceutical companies to develop new drugs. They are increasingly going beyond the border to collaborate with foreign companies or research institutes for global open innovation. Pharmaceutical industry watchers said there would be more cases of global
Comments Off on Korean Drugmakers Seek Global Collaboration for Open Innovation • Read this story »